The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
2Seventy Bio Inc | COMMON STOCK | 901384107 | 4,308,663 | 459,836 | SH | OTR | 459,836 | 0 | 0 | |||
89Bio Inc | COM | 282559103 | 17,822,000 | 1,400,000 | SH | OTR | 1,400,000 | 0 | 0 | |||
Akero Therapeutics Inc | COM | 00973Y108 | 45,565,926 | 831,495 | SH | OTR | 831,495 | 0 | 0 | |||
Alaunos Therapeutics Inc | COM | 98973P101 | 973,650 | 1,500,000 | SH | OTR | 1,500,000 | 0 | 0 | |||
Amicus Therapeutics Inc | COM | 03152W109 | 28,388,250 | 2,325,000 | SH | OTR | 2,325,000 | 0 | 0 | |||
Amylyx Pharmaceuticals Inc | COM | 03237H101 | 77,003,800 | 2,084,000 | SH | OTR | 2,084,000 | 0 | 0 | |||
AnaptysBio Inc | COM | 032724106 | 40,287,000 | 1,300,000 | SH | OTR | 1,300,000 | 0 | 0 | |||
Apellis Pharmaceuticals Inc | COM | 03753U106 | 81,494,960 | 1,576,000 | SH | OTR | 1,576,000 | 0 | 0 | |||
Arcus Biosciences Inc | COM | 03969F109 | 29,617,896 | 1,432,200 | SH | OTR | 1,432,200 | 0 | 0 | |||
Arvinas Inc | COM | 04335A105 | 5,131,500 | 150,000 | SH | OTR | 150,000 | 0 | 0 | |||
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 11,602,350 | 95,000 | SH | OTR | 95,000 | 0 | 0 | |||
Atreca Inc | CL A COM | 04965G109 | 1,763,188 | 2,202,333 | SH | OTR | 2,202,333 | 0 | 0 | |||
Avidity Biosciences Inc | COM | 05370A108 | 24,882,246 | 1,121,327 | SH | OTR | 1,121,327 | 0 | 0 | |||
Axsome Therapeutics Inc | COM | 05464T104 | 30,852,000 | 400,000 | SH | OTR | 400,000 | 0 | 0 | |||
BeiGene Ltd | SPONSORED ADR | 07725L102 | 109,970,000 | 500,000 | SH | OTR | 500,000 | 0 | 0 | |||
Bellicum Pharmaceuticals Inc | COM NEW | 079481404 | 41,004 | 56,950 | SH | OTR | 56,950 | 0 | 0 | |||
Bellus Health Inc New | COM NEW | 07987C204 | 26,304,000 | 3,200,000 | SH | OTR | 3,200,000 | 0 | 0 | |||
BioAtla Inc | COM | 09077B104 | 5,662,363 | 686,347 | SH | OTR | 686,347 | 0 | 0 | |||
Black Diamond Therapeutics I | COM | 09203E105 | 3,626,744 | 2,014,858 | SH | OTR | 2,014,858 | 0 | 0 | |||
Cabaletta Bio Inc | COM | 12674W109 | 4,995,000 | 540,000 | SH | OTR | 540,000 | 0 | 0 | |||
Centessa Pharmaceuticals PLC | SPONSORED ADS | 152309100 | 38,785,245 | 1,251,137 | SH | OTR | 1,251,137 | 0 | 0 | |||
Cogent Biosciences Inc | COM | 19240Q201 | 6,069,000 | 525,000 | SH | OTR | 525,000 | 0 | 0 | |||
Cullinan Oncology Inc | COM | 230031106 | 11,331,565 | 1,074,082 | SH | OTR | 1,074,082 | 0 | 0 | |||
Cytokinetics Inc | COM NEW | 23282W605 | 96,222,000 | 2,100,000 | SH | OTR | 2,100,000 | 0 | 0 | |||
Day One Biopharmaceuticals I | COM | 23954D109 | 25,607,573 | 1,189,943 | SH | OTR | 1,189,943 | 0 | 0 | |||
DBV Technologies S A | SPONSORED ADR | 23306J101 | 2,218,500 | 1,450,000 | SH | OTR | 1,450,000 | 0 | 0 | |||
Disc Medicine Inc | COM | 254604101 | 175,500 | 130,000 | SH | OTR | 130,000 | 0 | 0 | |||
EQRx Inc | COM | 26886C107 | 2,460,000 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 | |||
Exelixis Inc | COM | 30161Q104 | 18,446,000 | 1,150,000 | SH | OTR | 1,150,000 | 0 | 0 | |||
Fate Therapeutics Inc | COM | 31189P102 | 12,612,500 | 1,250,000 | SH | OTR | 1,250,000 | 0 | 0 | |||
Geron Corp | COM | 374163103 | 19,602,000 | 8,100,000 | SH | OTR | 8,100,000 | 0 | 0 | |||
Gossamer Bio Inc | COM | 38341P102 | 7,241,134 | 3,336,928 | SH | OTR | 3,336,928 | 0 | 0 | |||
Health Sciences Acq Corp 2 | ORD SHS | G4411D109 | 2,495,000 | 250,000 | SH | OTR | 250,000 | 0 | 0 | |||
Ideaya Biosciences Inc | COM | 45166A102 | 40,025,094 | 2,202,812 | SH | OTR | 2,202,812 | 0 | 0 | |||
Iovance Biotherapeutics Inc | COM | 462260100 | 9,617,800 | 1,505,133 | SH | OTR | 1,505,133 | 0 | 0 | |||
iTeos Therapeutics Inc | COM | 46565G104 | 42,068,752 | 2,154,058 | SH | OTR | 2,154,058 | 0 | 0 | |||
Iveric Bio Inc | COM | 46583P102 | 17,663,250 | 825,000 | SH | OTR | 825,000 | 0 | 0 | |||
Kinnate Biopharma Inc | COM | 49705R105 | 3,111,000 | 510,000 | SH | OTR | 510,000 | 0 | 0 | |||
MEI Pharma Inc | COM NEW | 55279B202 | 709,629 | 2,913,091 | SH | OTR | 2,913,091 | 0 | 0 | |||
Mereo Biopharma Group PLC | SPON ADS | 589492107 | 1,687,500 | 2,250,000 | SH | OTR | 2,250,000 | 0 | 0 | |||
Merus N V | COM | N5749R100 | 29,393,000 | 1,900,000 | SH | OTR | 1,900,000 | 0 | 0 | |||
Milestone Pharmaceuticals In | COM | 59935V107 | 2,767,490 | 698,861 | SH | OTR | 698,861 | 0 | 0 | |||
Mirati Therapeutics Inc | COM | 60468T105 | 90,620,000 | 2,000,000 | SH | OTR | 2,000,000 | 0 | 0 | |||
NGM Biopharmaceuticals Inc | COM | 62921N105 | 2,510,000 | 500,000 | SH | OTR | 500,000 | 0 | 0 | |||
Nurix Therapeutics Inc | COM | 67080M103 | 13,449,314 | 1,224,892 | SH | OTR | 1,224,892 | 0 | 0 | |||
Nuvalent Inc | COM | 670703107 | 36,039,518 | 1,210,192 | SH | OTR | 1,210,192 | 0 | 0 | |||
Nuvation Bio Inc | *W EXP 07/07/202 | 67080N119 | 38,533 | 266,666 | SH | OTR | 266,666 | 0 | 0 | |||
Oric Pharmaceuticals Inc | COM | 68622P109 | 7,362,401 | 1,054,000 | SH | OTR | 1,054,000 | 0 | 0 | |||
Panacea Acquisition Corp II | CL A SHS | G6882C106 | 6,208,060 | 500,000 | SH | OTR | 500,000 | 0 | 0 | |||
PMV Pharmaceuticals Inc | COM | 69353Y103 | 27,525,016 | 3,163,795 | SH | OTR | 3,163,795 | 0 | 0 | |||
Point Biopharma Global Inc | COM | 730541109 | 18,225,000 | 2,500,000 | SH | OTR | 2,500,000 | 0 | 0 | |||
Prometheus Biosciences Inc | COM | 74349U108 | 208,725,000 | 1,897,500 | SH | OTR | 1,897,500 | 0 | 0 | |||
Protara Therapeutics Inc | COM STK | 74365U107 | 560,728 | 209,227 | SH | OTR | 209,227 | 0 | 0 | |||
Prothena Corp PLC | SHS | G72800108 | 18,075,000 | 300,000 | SH | OTR | 300,000 | 0 | 0 | |||
Rain Oncology Inc | COM | 75082Q105 | 17,177,696 | 2,147,212 | SH | OTR | 2,147,212 | 0 | 0 | |||
Reata Pharmaceuticals Inc | CL A | 75615P103 | 46,727,852 | 1,230,004 | SH | OTR | 1,230,004 | 0 | 0 | |||
Relay Therapeutics Inc | COM | 75943R102 | 32,406,832 | 2,169,132 | SH | OTR | 2,169,132 | 0 | 0 | |||
Revolution Medicines Inc | COM | 76155X100 | 94,905,168 | 3,984,264 | SH | OTR | 3,984,264 | 0 | 0 | |||
Rocket Pharmaceuticals Inc | COM | 77313F106 | 28,690,618 | 1,466,051 | SH | OTR | 1,466,051 | 0 | 0 | |||
Sage Therapeutics Inc | COM | 78667J108 | 41,725,160 | 1,094,000 | SH | OTR | 1,094,000 | 0 | 0 | |||
Selecta Biosciences Inc | COM | 816212104 | 3,711,001 | 3,284,072 | SH | OTR | 3,284,072 | 0 | 0 | |||
Springworks Therapeutics Inc | COM | 85205L107 | 88,994,281 | 3,421,541 | SH | OTR | 3,421,541 | 0 | 0 | |||
Surrozen Inc | *W EXP 08/01/203 | 86889P117 | 4,393 | 66,666 | SH | OTR | 66,666 | 0 | 0 | |||
Tango Therapeutics Inc | COM | 87583X109 | 51,646,405 | 7,123,642 | SH | OTR | 7,123,642 | 0 | 0 | |||
Theseus Pharmaceuticals Inc | COM | 88369M101 | 2,066,700 | 415,000 | SH | OTR | 415,000 | 0 | 0 | |||
Third Harmonic Bio Inc | COM | 88427A107 | 2,452,793 | 570,417 | SH | OTR | 570,417 | 0 | 0 | |||
Tyra Biosciences Inc | COM | 90240B106 | 49,007,528 | 6,448,359 | SH | OTR | 6,448,359 | 0 | 0 | |||
Ventyx Biosciences Inc | COM | 92332V107 | 27,871,500 | 850,000 | SH | OTR | 850,000 | 0 | 0 | |||
Veru Inc | COM | 92536C103 | 1,833,744 | 347,300 | SH | OTR | 347,300 | 0 | 0 | |||
Viking Therapeutics Inc | COM | 92686J106 | 14,100,000 | 1,500,000 | SH | OTR | 1,500,000 | 0 | 0 | |||
Xenon Pharmaceuticals Inc | COM | 98420N105 | 23,658,000 | 600,000 | SH | OTR | 600,000 | 0 | 0 |